|
End-of-day quote
NSE India S.E.
2026-11-11
|
5-day change | 1st Jan Change | ||
| 1,429.00 INR | +0.13% |
|
+7.78% | +20.45% |
| 11-05 | Global Health Passes the Health Check But Challenges Remain |  |
| 11-04 | Global Health Limited, Q2 2027 Earnings Call, Nov 04, 2026 |
| Market Cap | 384B 4.1B 3.69B 3.41B 3.08B 5.83B 5.98B 40.88B 16.29B 206B 15.37B 15.05B 655B | P/E 2027 * |
50.2x | P/E 2028 * | 41.4x |
|---|---|---|---|---|---|
| Enterprise Value | 379B 4.04B 3.64B 3.36B 3.04B 5.75B 5.9B 40.32B 16.07B 203B 15.16B 14.84B 646B | EV / Sales 2027 * |
6.83x | EV / Sales 2028 * | 6.01x |
| Free-Float |
33.6% | Yield 2027 * |
0.04% | Yield 2028 * | 0.06% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| MEDANTA | End-of-day quote | |
Bombay S.E.
| MEDANTA | Delayed |
Last Transcript: Global Health Limited
| 1 day | +0.13% | ||
| 1 week | +7.78% | ||
| Current month | +12.49% | ||
| 1 month | +8.86% | ||
| 3 months | -3.20% | ||
| 6 months | +19.02% | ||
| Current year | +20.45% |
| 1 week | 1,380.7 |  | 1,451.5 |
| 1 month | 1,165 | | 1,451.5 |
| Current year | 956 | | 1,544 |
| 1 year | 956 | | 1,544 |
| 3 years | 881.3 | | 1,544 |
| 5 years | 390.55 | | 1,544 |
| 10 years | 390.55 | | 1,544 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2017-09-14 | |
| Director of Finance/CFO | 29 | 2024-02-07 | |
Rajiv Sikka
CTO | Chief Tech/Sci/R&D Officer | - | 2014-11-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 80 | 2014-02-06 | |
Sunil Sachdeva
BRD | Director/Board Member | 61 | 2004-08-12 |
| Director/Board Member | 72 | 2015-10-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +7.78% | +20.70% | +58.29% | 4.09B | |
| +0.57% | +11.96% | +12.08% | +32.04% | 114B | |
| +0.32% | -0.91% | +9.46% | +120.03% | 105B | |
| +2.51% | -18.21% | +54.71% | +558.88% | 45.24B | |
| -1.46% | +9.55% | +11.61% | +113.54% | 33.58B | |
| +0.36% | +1.21% | +38.78% | +82.10% | 30.12B | |
| +0.10% | +1.18% | +36.98% | +95.46% | 28.43B | |
| +0.93% | +0.25% | +47.73% | +433.93% | 23.1B | |
| -0.84% | +1.87% | -18.43% | -16.58% | 20.02B | |
| -0.13% | -0.39% | -5.96% | +31.24% | 16.86B | |
| Average | +0.04% | +1.42% | +20.77% | +150.89% | 42B | |
| Weighted average by Cap. | -0.10% | +1.03% | +19.43% | +145.08% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 55.49B 592M 533M 493M 445M 843M 863M 5.9B 2.35B 29.72B 2.22B 2.17B 94.58B | 63.06B 672M 606M 560M 506M 958M 981M 6.71B 2.67B 33.77B 2.52B 2.47B 107B |
| Net income | 7.66B 81.71M 73.64M 68.04M 61.51M 116M 119M 815M 325M 4.1B 307M 300M 13.06B | 9.32B 99.33M 89.53M 82.71M 74.78M 141M 145M 991M 395M 4.99B 373M 365M 15.88B |
| Net Debt | -5.31B -56.57M -50.99M -47.1M -42.58M -80.56M -82.55M -565M -225M -2.84B -212M -208M -9.04B | -4.98B -53.13M -47.89M -44.24M -40M -75.67M -77.54M -530M -211M -2.67B -199M -195M -8.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-10 | ₹1,429.00 | +0.13% | 218,117 |
| 26-11-09 | ₹1,427.10 | +2.12% | 232,833 |
| 26-11-08 | ₹1,397.50 | +0.71% | 10,236 |
| 26-11-06 | ₹1,387.60 | -0.15% | 104,406 |
| 26-11-05 | ₹1,389.70 | -0.88% | 256,509 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MEDANTA Stock
Select your edition
All financial news and data tailored to specific country editions
